288 related articles for article (PubMed ID: 28819584)
41. TGF-β1 pathway affects the protein expression of many signaling pathways, markers of liver cancer stem cells, cytokeratins, and TERT in liver cancer HepG2 cells.
Wang XH; Liu MN; Sun X; Xu CH; Liu J; Chen J; Xu RL; Li BX
Tumour Biol; 2016 Mar; 37(3):3675-81. PubMed ID: 26462837
[TBL] [Abstract][Full Text] [Related]
42. [Research Progress in the Therapeutic Strategy Based on Targeting at
Lung Cancer Stem Cell].
Lai H; Lin F; Chen N; Wen S; Hu X; Liu L
Zhongguo Fei Ai Za Zhi; 2018 Jan; 21(1):57-62. PubMed ID: 29357974
[TBL] [Abstract][Full Text] [Related]
43. Liver cancer stem cells: implications for a new therapeutic target.
Lee TK; Castilho A; Ma S; Ng IO
Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
[TBL] [Abstract][Full Text] [Related]
44. 8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signaling.
Ren KQ; Cao XZ; Liu ZH; Guo H; Quan MF; Liu F; Jiang L; Xiang HL; Deng XY; Cao JG
Int J Oncol; 2013 Nov; 43(5):1719-29. PubMed ID: 23970349
[TBL] [Abstract][Full Text] [Related]
45. The bad seed: Cancer stem cells in tumor development and resistance.
Koren E; Fuchs Y
Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
[TBL] [Abstract][Full Text] [Related]
46. Long noncoding RNA in liver cancer stem cells.
Cai Z; Xu K; Li Y; Lv Y; Bao J; Qiao L
Discov Med; 2017 Sep; 24(131):87-93. PubMed ID: 28972877
[TBL] [Abstract][Full Text] [Related]
47. Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells.
Xia W; Lo CM; Poon RYC; Cheung TT; Chan ACY; Chen L; Yang S; Tsao GSW; Wang XQ
Oncotarget; 2017 Jun; 8(24):38811-38824. PubMed ID: 28415588
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic Effectiveness of Anticancer Phytochemicals on Cancer Stem Cells.
Oh J; Hlatky L; Jeong YS; Kim D
Toxins (Basel); 2016 Jun; 8(7):. PubMed ID: 27376325
[TBL] [Abstract][Full Text] [Related]
49. Cancer stem cells in the development of liver cancer.
Yamashita T; Wang XW
J Clin Invest; 2013 May; 123(5):1911-8. PubMed ID: 23635789
[TBL] [Abstract][Full Text] [Related]
50. Cancer stem cell markers: premises and prospects.
Murar M; Vaidya A
Biomark Med; 2015; 9(12):1331-42. PubMed ID: 26612591
[TBL] [Abstract][Full Text] [Related]
51. Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells.
Li J; Condello S; Thomes-Pepin J; Ma X; Xia Y; Hurley TD; Matei D; Cheng JX
Cell Stem Cell; 2017 Mar; 20(3):303-314.e5. PubMed ID: 28041894
[TBL] [Abstract][Full Text] [Related]
52. C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.
Ng KY; Chai S; Tong M; Guan XY; Lin CH; Ching YP; Xie D; Cheng AS; Ma S
Oncotarget; 2016 Apr; 7(17):24005-17. PubMed ID: 27006468
[TBL] [Abstract][Full Text] [Related]
53. CD133 silencing inhibits stemness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stem cells.
Lan X; Wu YZ; Wang Y; Wu FR; Zang CB; Tang C; Cao S; Li SL
Int J Mol Med; 2013 Feb; 31(2):315-24. PubMed ID: 23233126
[TBL] [Abstract][Full Text] [Related]
54. Methods for cancer stem cell detection and isolation.
Tirino V; Desiderio V; Paino F; Papaccio G; De Rosa M
Methods Mol Biol; 2012; 879():513-29. PubMed ID: 22610581
[TBL] [Abstract][Full Text] [Related]
55. Targeting the mechano-microenvironment and liver cancer stem cells: a promising therapeutic strategy for liver cancer.
Fu X; Zhang Y; Luo Q; Ju Y; Song G
Cancer Biol Med; 2023 Nov; 20(11):816-29. PubMed ID: 38009775
[TBL] [Abstract][Full Text] [Related]
56. Expression of cancer stem cell markers in metastatic colorectal cancer correlates with liver metastasis, but not with metastasis to the central nervous system.
Michl M; Heinemann V; Jung A; Engel J; Kirchner T; Neumann J
Pathol Res Pract; 2015 Aug; 211(8):601-9. PubMed ID: 26092596
[TBL] [Abstract][Full Text] [Related]
57. CD26 a cancer stem cell marker and therapeutic target.
Davies S; Beckenkamp A; Buffon A
Biomed Pharmacother; 2015 Apr; 71():135-8. PubMed ID: 25960228
[TBL] [Abstract][Full Text] [Related]
58. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
59. Isolation and Characterization of Cancer Stem Cells of the Non-Small-Cell Lung Cancer (A549) Cell Line.
Halim NHA; Zakaria N; Satar NA; Yahaya BH
Methods Mol Biol; 2016; 1516():371-388. PubMed ID: 27032945
[TBL] [Abstract][Full Text] [Related]
60. Current status and issues in cancer stem cell study.
Yang YM; Chang JW
Cancer Invest; 2008 Aug; 26(7):741-55. PubMed ID: 18608212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
